Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033

Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5438

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Oncology Based In-Vivo CRO Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Indication
    6.1    Blood Cancer
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Solid Tumors
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Model
    7.1    Syngeneic
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Xenograft
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Patient Derived Xenograft (PDX)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Application
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Rehabilitation Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Champions Oncology Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
        14.3.2    Charles River Laboratories International Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Crown Bioscience Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Eurofins Scientific
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Evotec SE
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    ICON Plc
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Labcorp Drug Development (Laboratory Corporation of America Holdings)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 SWOT Analysis
        14.3.8    Living Tumor Laboratory
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Taconic Biosciences Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    The Jackson Laboratory
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    WuXi AppTec
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    Xentech
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

​Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2024
Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2024
Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2024
Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2024
Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2024
Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million USD), 2025-2033
Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players

Oncology Based In-Vivo CRO Market Report by Indication (Blood Cancer, Solid Tumors, and Others), Model (Syngeneic, Xenograft, Patient Derived Xenograft (PDX), and Others), Application (Hospitals, Rehabilitation Centers), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials